Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cavitation Technologies (CVAT) Shares Outstanding (Diluted Average) (2016 - 2025)

Cavitation Technologies' Shares Outstanding (Diluted Average) history spans 8 years, with the latest figure at $301.2 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) rose 5.94% year-over-year to $301.2 million; the TTM value through Dec 2025 reached $301.2 million, up 5.94%, while the annual FY2025 figure was $286.0 million, 0.6% up from the prior year.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $301.2 million at Cavitation Technologies, up from $289.2 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $301.2 million in Q4 2025 and bottomed at $285005.1 in Q1 2025.
  • The 5-year median for Shares Outstanding (Diluted Average) is $279.4 million (2023), against an average of $252.9 million.
  • The largest annual shift saw Shares Outstanding (Diluted Average) skyrocketed 36.36% in 2022 before it plummeted 99.9% in 2025.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $232.7 million in 2021, then grew by 18.91% to $276.7 million in 2022, then grew by 2.74% to $284.3 million in 2023, then changed by 0.0% to $284.3 million in 2024, then rose by 5.94% to $301.2 million in 2025.
  • Per Business Quant, the three most recent readings for CVAT's Shares Outstanding (Diluted Average) are $301.2 million (Q4 2025), $289.2 million (Q3 2025), and $286.0 million (Q2 2025).